Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis (OSTEOAD)

Procare Health

Status: Enrolling

Conditions: Post Menopausal Osteoporosis

Study type: Observational

Funder types: Industry

Identifiers

NCT07105163

OSTEOAD

Details and patient eligibility

About

This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usual treatments for postmenopausal osteoporosis. The study will consist of a single visit that will coincide with one of the patient's usual follow-up visits according to standard clinical practice. During this visit, information will be collected from the patient's medical history and an interview will be conducted using 3 questionnaires to assess how and how often the patient takes the treatment, possible forgetfulness, and whether or not the patient is satisfied with their current treatment.

Enrollment: 480 estimated patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

1. • Women diagnosed with postmenopausal OP.
2. • Women who had been prescribed oral treatment with a BP administered monthly or weekly together with a Ca/D supplement (sachets or chewable tablets) administered daily, at least 6 months prior to inclusion in the study.
3. • Women who had given their written informed consent before participating in the study.

Exclusion criteria

None